Published December 13, 2022
Jamia Fernandes v. Centessa Pharmaceuticals plc, et al., 1:22-cv-08805-GHW-SLC is a lawsuit currently pending in the United States District Court for the Southern District of New York. The action was filed on behalf of investors in Centessa Pharmaceuticals plc (NASDAQ: CNTA) who allegedly suffered losses due to securities fraud by the company.
On December 12, 2022, United States Magistrate Judge Sarah L. Cave signed an order appointing Co-Lead Plaintiffs and appointing Levi & Korsinsky, LLP and Pomerantz LLP as Co-Lead Counsel for the class. A copy of the order can be viewed here.